Summary of Alignment Healthcare's Q3 2025 Earnings Call

1Key Financial Results and Metrics

Health Plan Membership: Grew to 229,600 members, a 26% increase year-over-year.

Total Revenue: Reached $994 million, up 44% year-over-year.

Adjusted Gross Profit: Increased to $127 million, a 58% year-over-year growth, with a Medical Benefit Ratio (MBR) of 87.2%, improving by 120 basis points.

Adjusted SG&A Ratio: Improved to 9.6%, a reduction of 120 basis points year-over-year.

Adjusted EBITDA: Reported at $32 million, exceeding guidance, with an adjusted EBITDA margin of 3.3%, reflecting a 240 basis point increase year-over-year.

Cash Position: Ended the quarter with $644 million in cash, cash equivalents, and investments.

2Strategic Updates and Business Highlights

Star Ratings: 100% of health plan members are in plans rated 4 stars or above for rating year 2026, significantly outperforming the national average of 63%. Notable achievements include two 5-star contracts in North Carolina and Nevada, and a 4.5-star rating in Texas.

Operational Investments: Continued investments in back-office automation, clinical engagement, and AVA AI clinical stratification to enhance care delivery and operational efficiency.

Market Positioning: The company is well-positioned to capitalize on industry disruptions and is focused on maintaining a balance between membership growth and profitability.

3Forward Guidance and Outlook

Q4 2025 Guidance:

Membership expected between 232,500 and 234,500.

Revenue forecasted between $995 million and $1.01 billion.

Adjusted gross profit anticipated between $104 million and $113 million.

Adjusted EBITDA projected to be between negative $9 million and negative $1 million.

Full Year 2025 Guidance:

Revenue expected between $3.93 billion and $3.95 billion.

Adjusted gross profit between $474 million and $483 million.

Adjusted EBITDA forecasted between $90 million and $98 million.

2026 Growth Expectations: Confident in achieving at least 20% membership growth, supported by early selling season results.

4Bad News, Challenges, or Points of Concern

Increased Utilization: Anticipated higher medical utilization in Q4 due to seasonal flu impacts, which could affect MBR.

Part D Program Changes: Continued caution regarding assumptions related to Part D due to significant changes in the program.

Competitive Pressures: The Medicare Advantage (MA) market is expected to face headwinds, with some competitors anticipating enrollment declines, which may impact overall market growth.

5Notable Q&A Insights

Market Share Dynamics: The company is experiencing strong growth in both gross new adds and retention, with 80-85% of new members switching from other plans.

M&A Considerations: The company is selectively exploring M&A opportunities, particularly in supplemental benefits, while maintaining a cautious approach to entering new markets.

Risk Sharing with Providers: Approximately 65-70% of the business is under shared risk arrangements, which have improved clinical and financial outcomes.

Brand Investment: Plans to invest in brand marketing to enhance member acquisition and reinforce the company’s value proposition in Medicare Advantage.

RADV Preparedness: The company is well-prepared for potential RADV audits, maintaining strong compliance and documentation processes. This summary encapsulates the key financial metrics, strategic initiatives, forward guidance, and notable insights from the Q&A, providing a comprehensive overview of Alignment Healthcare's performance and outlook.